IMS Risk Management Tool Targets "High Risk" MDs: CERTs Conference
Executive Summary
IMS Health is developing a risk management tool that would target "high risk" prescribers for interventions, the company told an April 29-May 1 risk communication workshop.
You may also be interested in...
Rx Risk Descriptions Need To Be Standardized, FDA’s Galson Tells CERTs
The standardization of risk expressions to compare drugs would be a desirable risk management tool, Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, suggested at a recent CERTs meeting
Rx Risk Descriptions Need To Be Standardized, FDA’s Galson Tells CERTs
The standardization of risk expressions to compare drugs would be a desirable risk management tool, Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, suggested at a recent CERTs meeting
Drug Risk Assessment Needs IoM Report To Synthesize Research – CERTs
The Institute of Medicine should study the current state of pharmaceutical risk assessment and recommend methodological and research improvements, participants in a Centers for Education & Research on Therapeutics risk assessment workshop suggested